Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Firas El-Saleh"'
Autor:
Christian Muehlenfeld, Patrick Duffy, Fengyuan Yang, David Zermeño Pérez, Firas El-Saleh, Thomas Durig
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 317 (2024)
This review provides a comprehensive overview of additive manufacturing (AM) or 3D-printing (3DP) applications in the pharmaceutical industry, with a particular focus on the critical role of polymer selection. By providing insights into how material
Externí odkaz:
https://doaj.org/article/1c11917963c540599ac88e6c5e90968d
Autor:
Susana Santos Braga, Jéssica S. Barbosa, Nádia E. Santos, Firas El-Saleh, Filipe A. Almeida Paz
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 499 (2022)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/673b8fd686724dcc90413521438563a3
Autor:
Susana Santos Braga, Jéssica S. Barbosa, Nádia E. Santos, Firas El-Saleh, Filipe A. Almeida Paz
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 409 (2021)
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins—solubilisation and stabilisation of
Externí odkaz:
https://doaj.org/article/3a0b877b371447999f0686c2d5aeab9b
Publikováno v:
Molecules, Vol 26, Iss 3, p 519 (2021)
Efavirenz is an antiretroviral drug of widespread use in the management of infections with human immunodeficiency virus type 1 (HIV-1). Efavirenz is also used in paediatrics, but due to its very poor aqueous solubility the liquid formulations availab
Externí odkaz:
https://doaj.org/article/9106d8dbe4f54fc6be330721a4d4a01c
Publikováno v:
Pharmaceutics, Vol 13, Iss 409, p 409 (2021)
Pharmaceutics
Pharmaceutics
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins—solubilisation and stabilisation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d81493bedf4b43169a9aee3e53c655
https://www.mdpi.com/1999-4923/13/3/409
https://www.mdpi.com/1999-4923/13/3/409
Publikováno v:
Molecules
Volume 26
Issue 3
Molecules, Vol 26, Iss 519, p 519 (2021)
Volume 26
Issue 3
Molecules, Vol 26, Iss 519, p 519 (2021)
Efavirenz is an antiretroviral drug of widespread use in the management of infections with human immunodeficiency virus type 1 (HIV-1). Efavirenz is also used in paediatrics, but due to its very poor aqueous solubility the liquid formulations availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6739bbe46a8704be2a1367601c75aef0
Publikováno v:
The 1st International Electronic Conference on Pharmaceutics.
This short paper investigates the solubilizing ability of various cyclodextrins with efavirenz as well as the formation of solid inclusion complexes of efavirenz with β-CD and γ-CD. (1) Background: Efavirenz is a non-nucleoside reverse transcriptas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21906e05232d5caad0f8fd74d76cccf9
https://doi.org/10.3390/iecp2020-08690
https://doi.org/10.3390/iecp2020-08690
Autor:
Firas El-Saleh, Tugce Tuglu, Julian Quodbach, Edmont Stoyanov, Christian Muehlenfeld, Nadin Ekmekciyan
Publikováno v:
International Journal of Pharmaceutics. 548:491-499
The understanding of tablet disintegration is still incomplete as not all involved factors and processes are known or accounted for. E.g., the negative influence of soluble fillers, on disintegration is usually attributed to increased viscosity due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f9b59d1de6990b90c488284018e99a
https://doi.org/10.1016/j.ijpharm.2018.07.025
https://doi.org/10.1016/j.ijpharm.2018.07.025
Publikováno v:
Handbook of Pharmaceutical Granulation Technology ISBN: 9780429103612
Handbook of Pharmaceutical Granulation Technology ISBN: 9780429320057
Handbook of Pharmaceutical Granulation Technology ISBN: 9780429320057
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b8e73b40cb63b49ec271eb6a71b6fb
https://doi.org/10.3109/9781616310035-21
https://doi.org/10.3109/9781616310035-21
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 56:255-260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d741ae6295fb4ca3fbf446880c4b818
https://doi.org/10.1016/s0939-6411(03)00090-0
https://doi.org/10.1016/s0939-6411(03)00090-0